Ultra-processed Food-reducing Intervention and Continuous Glucose Monitoring — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Ultra-processed Food-reducing Intervention and Continuous Glucose Monitoring — Stella

Recruiting

Back to Postprandial Glucose trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

South Korea

Health Promotion Lab, College of Health Science, Korea University, Seoul, Seoul

Key details

Sponsor

Korea University

Collaborators

Korean Society of Cardiometabolic Syndrome (funder)

Enrollment target

~50 participants

Started

October 2025

Primary completion

August 2026

Age range

20 Years – 39 Years

Last updated April 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov